Status:
UNKNOWN
Clinical Validation of Cervical Cancer Screening Methods
Lead Sponsor:
N.N. Petrov National Medical Research Center of Oncology
Conditions:
Cervical Cancer
Cervical Dysplasia
Eligibility:
FEMALE
25-65 years
Brief Summary
This single-institution cross-sectional non-inferiority validation study evaluates alternative techniques and tests for primary cervical cancer screening programs in Russia, particularly: local cytolo...
Detailed Description
Cervical cytology practices are different across the world. While the Pap test became the cornerstone of the highly-effective cervical cancer screening in the countries that initially implemented popu...
Eligibility Criteria
Inclusion
- Age between 25 and 65 years old Referral to colposcopy or to a primary screening test Signed informed consent
Exclusion
- Prior history of malignancy or cervical dysplasia Prior history of cervical dysplasia
Key Trial Info
Start Date :
July 13 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2023
Estimated Enrollment :
2500 Patients enrolled
Trial Details
Trial ID
NCT04783649
Start Date
July 13 2020
End Date
July 1 2023
Last Update
March 5 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
N.N. Petrov National Medical Research Center of Oncology
Saint Petersburg, Russia, 197758